Genomics of Drug Sensitivity in Cancer Crizotinib
Synonyms Xalkori, PF2341066, PF-2341066, PF 2341066
Targets MET, ALK, ROS1
Target pathway RTK signaling
PubCHEM ID 11626560
Jsmol
Download molecule 11626560
PUBCHEM IUPAC INCHI InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1
Smiles ClC1(=C(F)C=CC(=C1C(OC2(=C(N=CC(=C2)C=3(C=NN(C=3)C4(CCNCC4)))N))C)Cl)
Cluster number 66
calculated LogS -5,264
Molecular weight 450,344
calculated LogP 3,5382
H-Acceptors 6
H-Donors 2
Ro5 violations 0
Druglikeness 3,1708
DrugScore 0,523528594869751
Mutagenic none
Tumorigenic none
Reproductive Effective none
Irritant none
Fish Toxicity High FHMT
Fish Toxicity2 1,4194
Rat Acute Toxicity 2,6581
Acute Oral Toxicity III
Caco-2 Permeability Caco2-
Caco-2 Permeability2 0,9016
P-glycoprotein Substrate Substrate
P-glycoprotein Inhibitor Non-inhibitor
P-glycoprotein Inhibitor2 Inhibitor
Human Ether-a-go-go-Related Gene Inhibition Strong inhibitor
Human Ether-a-go-go-Related Gene Inhibition2 Inhibitor
Tetrahymena Pyriformis Toxicity High TPT
Tetrahymena Pyriformis Toxicity2 0,4904
AMES Toxicity Non AMES toxic
CYP450 2C9 Substrate Non-substrate
CYP450 3A4 Substrate Substrate
CYP450 3A4 Inhibitor Non-inhibitor
CYP450 2C19 Inhibitor Inhibitor
CYP450 2C9 Inhibitor Inhibitor
CYP450 2D6 Inhibitor Non-inhibitor
CYP450 1A2 Inhibitor Inhibitor
CYP450 2D6 Substrate Non-substrate
Biodegradation Not ready biodegradable
Carcinogenicity (Three-class) Non-carcinogens
Carcinogens Non-required
Blood-Brain Barrier BBB+
CYP Inhibitory Promiscuity High CYP Inhibitory Promiscuity
Honey Bee Toxicity Low HBT
Renal Organic Cation Transporter Inhibitor
Subcellular localization Mitochondria
Human Intestinal Absorption HIA+
Aqueous solubility -2,932
Information useful only for research purposes.